Cargando…

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach

Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary HIV-coinfection model of care integrating sub-specialty services in 3 countries. Of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cachay, Edward R., Mena, Alvaro, Morano, Luis, Benitez, Laura, Maida, Ivana, Mendoza, Carmen DE, Hill, Lucas, Torriani, Francesca, Soriano, Vincente, Mathews, W. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212364/ https://www.ncbi.nlm.nih.gov/pubmed/34132142 http://dx.doi.org/10.1177/23259582211024771

Ejemplares similares

Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus
por: Cachay, Edward R, et al.
Publicado: (2019)

Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model
por: Cachay, Edward R, et al.
Publicado: (2013)

The Hepatitis C Cascade of Care among HIV Infected Patients: A Call to Address Ongoing Barriers to Care
por: Cachay, Edward R., et al.
Publicado: (2014)

Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV
por: Cachay, Edward R, et al.
Publicado: (2018)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
por: Kandula, Manasa, et al.
Publicado: (2016)

Screening for Sexually Transmitted Infections During Hepatitis C Treatment to Predict Reinfection Among People With HIV
por: Hill, Lucas A, et al.
Publicado: (2020)

Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment
por: Cachay, Edward R., et al.
Publicado: (2017)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
por: Pérez-Latorre, Leire, et al.
Publicado: (2018)

Fatal Invasive Cryptococcal Infection in an HIV-Negative Elderly Patient with Decompensated Hepatic Cirrhosis
por: Koba, Shigeru, et al.
Publicado: (2018)

Hepatitis C Virus Micro-elimination Among People With HIV in San Diego: Are We on Track?
por: Cheema, Jaskaran S, et al.
Publicado: (2023)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment
por: Cachay, Edward R, et al.
Publicado: (2011)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review
por: O’Connell, Malene Barfod, et al.
Publicado: (2023)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care
por: Cachay, Edward R., et al.
Publicado: (2015)

Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis
por: VoPham, Trang, et al.
Publicado: (2023)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
por: Shailesh, F. N. U., et al.
Publicado: (2014)

Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2016)

Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis
por: Alvarez-Silva, Camila, et al.
Publicado: (2019)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Impact of Bacterial Translocation on Sarcopenia in Patients with Decompensated Cirrhosis
por: Tsien, Cynthia, et al.
Publicado: (2019)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis
por: Tocia, Cristina, et al.
Publicado: (2020)

Clostridioides difficile Induced Rhabdomyolysis Associated With Decompensated Cirrhosis
por: Dungan, William, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j3do30qa4l6tkv63n38dnb6ap2